{"transactions":[{"id":751154,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2026-06-03T20:05:12.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":573888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award vests in three substantially equal annual installments beginning on February 18, 2027, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Award vests in three substantially equal annual installments beginning on February 18, 2027, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":573888,"derivative":{"underlying":"Common Stock","underlying_shares":573888},"source":{"system":"sec-edgar","filing":"0001628280-26-040212","document":"wk-form4_1780517107.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000162828026040212/wk-form4_1780517107.xml","form_type":"4"}},{"id":892876,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2026-02-19T21:31:08.000Z","date":"2026-02-17","kind":"exercise","planned":true,"acquired":false,"shares":67797,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"RSUs vests in three substantially equal annual installments beginning on February 17, 2026, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"RSUs vests in three substantially equal annual installments beginning on February 17, 2026, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":135593,"derivative":{"underlying":"Common Stock","underlying_shares":67797},"source":{"system":"sec-edgar","filing":"0001628280-26-009804","document":"wk-form4_1771536666.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000162828026009804/wk-form4_1771536666.xml","form_type":"4"}},{"id":892875,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-19T21:31:08.000Z","date":"2026-02-18","kind":"sale","planned":true,"acquired":false,"shares":20559,"price":3.84,"value":78946.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales were effected pursuant to a Rule 10b5-1 plan adopted on August 2, 2024. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees."}],"balance_after":243392,"source":{"system":"sec-edgar","filing":"0001628280-26-009804","document":"wk-form4_1771536666.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000162828026009804/wk-form4_1771536666.xml","form_type":"4"}},{"id":892874,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-19T21:31:08.000Z","date":"2026-02-17","kind":"exercise","planned":true,"acquired":true,"shares":67797,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the vesting of Restricted Stock Units (\"RSUs\") on February 17, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":263951,"source":{"system":"sec-edgar","filing":"0001628280-26-009804","document":"wk-form4_1771536666.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000162828026009804/wk-form4_1771536666.xml","form_type":"4"}},{"id":930628,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-27T21:30:22.000Z","date":"2026-01-26","kind":"grant","planned":false,"acquired":true,"shares":37313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All of the restricted stock will vest on January 26, 2027."}],"balance_after":217779,"source":{"system":"sec-edgar","filing":"0001493152-26-003806","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226003806/ownership.xml","form_type":"4"}},{"id":933267,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2026-01-22T23:49:01.000Z","date":"2026-01-20","kind":"exercise","planned":true,"acquired":false,"shares":69421,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On August 22, 2024 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"On August 22, 2024 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":69421,"derivative":{"underlying":"Common Stock","underlying_shares":69421},"source":{"system":"sec-edgar","filing":"0001628280-26-003149","document":"wk-form4_1769125738.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000162828026003149/wk-form4_1769125738.xml","form_type":"4"}},{"id":933266,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2026-01-22T23:49:01.000Z","date":"2026-01-20","kind":"exercise","planned":true,"acquired":false,"shares":37069,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On April 18, 2024 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On April 18, 2024 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":37069,"derivative":{"underlying":"Common Stock","underlying_shares":37069},"source":{"system":"sec-edgar","filing":"0001628280-26-003149","document":"wk-form4_1769125738.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000162828026003149/wk-form4_1769125738.xml","form_type":"4"}},{"id":933265,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2026-01-22T23:49:01.000Z","date":"2026-01-20","kind":"exercise","planned":true,"acquired":false,"shares":8888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On January 20, 2023 the Reporting Person was granted RSUs, which vested in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On January 20, 2023 the Reporting Person was granted RSUs, which vested in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8888},"source":{"system":"sec-edgar","filing":"0001628280-26-003149","document":"wk-form4_1769125738.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000162828026003149/wk-form4_1769125738.xml","form_type":"4"}},{"id":933264,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-01-22T23:49:01.000Z","date":"2026-01-22","kind":"sale","planned":true,"acquired":false,"shares":34799,"price":4.17,"value":145111.83,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales were effected pursuant to a Rule 10b5-1 plan adopted on August 2, 2024. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.97 to $4.30. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote"}],"balance_after":196154,"source":{"system":"sec-edgar","filing":"0001628280-26-003149","document":"wk-form4_1769125738.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000162828026003149/wk-form4_1769125738.xml","form_type":"4"}},{"id":933263,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-01-22T23:49:01.000Z","date":"2026-01-20","kind":"exercise","planned":true,"acquired":true,"shares":69421,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the vesting of Restricted Stock Units (\"RSUs\") on January 20, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":230953,"source":{"system":"sec-edgar","filing":"0001628280-26-003149","document":"wk-form4_1769125738.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000162828026003149/wk-form4_1769125738.xml","form_type":"4"}},{"id":933262,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-01-22T23:49:01.000Z","date":"2026-01-20","kind":"exercise","planned":true,"acquired":true,"shares":37069,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the vesting of Restricted Stock Units (\"RSUs\") on January 20, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":161532,"source":{"system":"sec-edgar","filing":"0001628280-26-003149","document":"wk-form4_1769125738.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000162828026003149/wk-form4_1769125738.xml","form_type":"4"}},{"id":933261,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-01-22T23:49:01.000Z","date":"2026-01-20","kind":"exercise","planned":true,"acquired":true,"shares":8888,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the vesting of Restricted Stock Units (\"RSUs\") on January 20, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":124463,"source":{"system":"sec-edgar","filing":"0001628280-26-003149","document":"wk-form4_1769125738.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000162828026003149/wk-form4_1769125738.xml","form_type":"4"}},{"id":1007921,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2025-11-04T21:15:28.000Z","date":"2025-11-03","kind":"exercise","planned":true,"acquired":false,"shares":9444,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on November 2, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on November 2, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":9444},"source":{"system":"sec-edgar","filing":"0001628280-25-048855","document":"wk-form4_1762290924.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000162828025048855/wk-form4_1762290924.xml","form_type":"4"}},{"id":1007920,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-11-04T21:15:28.000Z","date":"2025-11-03","kind":"sale","planned":true,"acquired":false,"shares":3409,"price":6.49,"value":22124.41,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales were effected pursuant to a Rule 10b5-1 plan adopted on August 2, 2024. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees."}],"balance_after":115575,"source":{"system":"sec-edgar","filing":"0001628280-25-048855","document":"wk-form4_1762290924.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000162828025048855/wk-form4_1762290924.xml","form_type":"4"}},{"id":1007919,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-11-04T21:15:28.000Z","date":"2025-11-02","kind":"exercise","planned":true,"acquired":true,"shares":9444,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the vesting and settlement of Restricted Stock Units (\"RSUs\") on November 2, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":118984,"source":{"system":"sec-edgar","filing":"0001628280-25-048855","document":"wk-form4_1762290924.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000162828025048855/wk-form4_1762290924.xml","form_type":"4"}},{"id":1122531,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2025-06-04T21:00:38.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":203390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award vests in three substantially equal annual installments beginning on February 17, 2026, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Award vests in three substantially equal annual installments beginning on February 17, 2026, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":203390,"derivative":{"underlying":"Common Stock","underlying_shares":203390},"source":{"system":"sec-edgar","filing":"0000950170-25-081721","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000095017025081721/ownership.xml","form_type":"4"}},{"id":1192032,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2025-03-25T22:00:06.000Z","date":"2025-03-21","kind":"exercise","planned":true,"acquired":false,"shares":3417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 21, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 21, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on March 21, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 21, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 21, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on March 21, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3417},"source":{"system":"sec-edgar","filing":"0000950170-25-044599","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000095017025044599/ownership.xml","form_type":"4"}},{"id":1192031,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-03-25T22:00:06.000Z","date":"2025-03-24","kind":"sale","planned":true,"acquired":false,"shares":964,"price":5.56,"value":5359.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales were effected pursuant to a Rule 10b5-1 plan adopted on August 2, 2024. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees."}],"balance_after":109540,"source":{"system":"sec-edgar","filing":"0000950170-25-044599","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000095017025044599/ownership.xml","form_type":"4"}},{"id":1192030,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-03-25T22:00:06.000Z","date":"2025-03-21","kind":"exercise","planned":true,"acquired":true,"shares":3417,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the vesting of Restricted Stock Units (\"RSUs\") on March 21, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":110504,"source":{"system":"sec-edgar","filing":"0000950170-25-044599","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000095017025044599/ownership.xml","form_type":"4"}},{"id":1288479,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-04T01:37:44.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":36101,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Upon vesting, a portion of the restricted stock may be surrendered to satisfy the reporting person's tax withholding obligation. Any deemed disposition of the withheld shares would be exempt pursuant to Rule 16b-3(e)."},{"field":"shares","element":"transactionShares","label":"F2","text":"All of the restricted stock will vest on January 31, 2026."}],"balance_after":180466,"source":{"system":"sec-edgar","filing":"0001493152-25-004750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315225004750/ownership.xml","form_type":"4"}},{"id":1297317,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2025-01-23T02:00:06.000Z","date":"2025-01-20","kind":"exercise","planned":true,"acquired":false,"shares":69421,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On August 22, 2024 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On August 22, 2024 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":138842,"derivative":{"underlying":"Common Stock","underlying_shares":69421},"source":{"system":"sec-edgar","filing":"0000950170-25-008013","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000095017025008013/ownership.xml","form_type":"4"}},{"id":1297316,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2025-01-23T02:00:06.000Z","date":"2025-01-20","kind":"exercise","planned":true,"acquired":false,"shares":37079,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On April 18, 2024 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On April 18, 2024 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":74138,"derivative":{"underlying":"Common Stock","underlying_shares":37079},"source":{"system":"sec-edgar","filing":"0000950170-25-008013","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000095017025008013/ownership.xml","form_type":"4"}},{"id":1297315,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2025-01-23T02:00:06.000Z","date":"2025-01-20","kind":"exercise","planned":true,"acquired":false,"shares":8888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":8888,"derivative":{"underlying":"Common Stock","underlying_shares":8888},"source":{"system":"sec-edgar","filing":"0000950170-25-008013","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000095017025008013/ownership.xml","form_type":"4"}},{"id":1297314,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-01-23T02:00:06.000Z","date":"2025-01-21","kind":"sale","planned":true,"acquired":false,"shares":36838,"price":4.67,"value":172033.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales were effected pursuant to a Rule 10b5-1 plan adopted on August 2, 2024. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees."}],"balance_after":107087,"source":{"system":"sec-edgar","filing":"0000950170-25-008013","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000095017025008013/ownership.xml","form_type":"4"}},{"id":1297313,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-01-23T02:00:06.000Z","date":"2025-01-20","kind":"exercise","planned":true,"acquired":true,"shares":115388,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the partial vesting and settlement of Restricted Stock Units (\"RSUs\") on January 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":143925,"source":{"system":"sec-edgar","filing":"0000950170-25-008013","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000095017025008013/ownership.xml","form_type":"4"}},{"id":1375106,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2024-11-06T00:14:05.000Z","date":"2024-11-02","kind":"exercise","planned":false,"acquired":false,"shares":9443,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":9444,"derivative":{"underlying":"Common Stock","underlying_shares":9443},"source":{"system":"sec-edgar","filing":"0000950170-24-121726","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000095017024121726/ownership.xml","form_type":"4"}},{"id":1375105,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-11-06T00:14:05.000Z","date":"2024-11-04","kind":"sale","planned":false,"acquired":false,"shares":3012,"price":8.19,"value":24668.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees."}],"balance_after":28537,"source":{"system":"sec-edgar","filing":"0000950170-24-121726","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000095017024121726/ownership.xml","form_type":"4"}},{"id":1375104,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-11-06T00:14:05.000Z","date":"2024-11-02","kind":"exercise","planned":false,"acquired":true,"shares":9443,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the vesting of Restricted Stock Units (\"RSUs\") on November 2, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":31549,"source":{"system":"sec-edgar","filing":"0000950170-24-121726","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000095017024121726/ownership.xml","form_type":"4"}},{"id":1422645,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-27T23:07:07.000Z","date":"2024-08-26","kind":"grant","planned":false,"acquired":true,"shares":11797,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The acquisition was exempt pursuant to Rule 16b-3(d)."},{"field":"shares","element":"transactionShares","label":"F2","text":"This stock grant represents the remainder of the 2024 annual grant to board of directors. This portion of the annual stock grant was withheld until all employees/management were allocated their shares and in order to enable onboarding of two new Board members. All of the restricted stock will vest on August 26, 2025."}],"balance_after":144365,"source":{"system":"sec-edgar","filing":"0001493152-24-034052","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315224034052/ownership.xml","form_type":"4"}},{"id":1424070,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2024-08-23T11:30:04.000Z","date":"2024-08-22","kind":"grant","planned":false,"acquired":true,"shares":208263,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award vests in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Award vests in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":208263,"derivative":{"underlying":"Common Stock","underlying_shares":208263},"source":{"system":"sec-edgar","filing":"0000950170-24-100019","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000095017024100019/ownership.xml","form_type":"4"}},{"id":1458007,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-09T20:35:35.000Z","date":"2024-07-08","kind":"grant","planned":false,"acquired":true,"shares":23611,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All of the restricted stock will vest on July 8, 2025."}],"balance_after":132568,"source":{"system":"sec-edgar","filing":"0001493152-24-026645","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315224026645/ownership.xml","form_type":"4"}},{"id":1523076,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-05-09T00:26:23.000Z","date":"2024-05-08","kind":"grant","planned":false,"acquired":true,"shares":8334,"price":12,"value":100008.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares purchased through a definitive subscription agreement, pursuant to which the Issuer agreed to issue and sell shares of its common stock in a non-brokered private placement to certain members of its management."}],"balance_after":22106,"source":{"system":"sec-edgar","filing":"0000950170-24-056141","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000095017024056141/ownership.xml","form_type":"4"}},{"id":1527624,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2024-05-03T22:29:28.000Z","date":"2024-05-01","kind":"exercise","planned":false,"acquired":false,"shares":3417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On March 21, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 21, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On March 21, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 21, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":3417,"derivative":{"underlying":"Common Stock","underlying_shares":3417},"source":{"system":"sec-edgar","filing":"0000950170-24-053112","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000095017024053112/ownership.xml","form_type":"4"}},{"id":1527623,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-05-03T22:29:28.000Z","date":"2024-05-02","kind":"sale","planned":false,"acquired":false,"shares":1526,"price":10.32,"value":15748.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The sales were effected pursuant to a Rule 10b5-1 plan adopted on March 24, 2022. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.11 to $10.53. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote."}],"balance_after":13772,"source":{"system":"sec-edgar","filing":"0000950170-24-053112","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000095017024053112/ownership.xml","form_type":"4"}},{"id":1527622,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-05-03T22:29:28.000Z","date":"2024-05-01","kind":"exercise","planned":false,"acquired":true,"shares":3417,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the partial vesting of Restricted Stock Units (\"RSUs\") on March 21, 2024, and subsequent settlement of such vested RSUs on May 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On February 13, 2024, the Issuer effected a 1-for-30 reverse stock split. The amounts of securities herein have been adjusted to reflect the reverse stock split."}],"balance_after":15298,"source":{"system":"sec-edgar","filing":"0000950170-24-053112","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000095017024053112/ownership.xml","form_type":"4"}},{"id":1537459,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2024-04-23T01:12:39.000Z","date":"2024-04-18","kind":"grant","planned":false,"acquired":true,"shares":111217,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award vests in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Award vests in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":111217,"derivative":{"underlying":"Common Stock","underlying_shares":111217},"source":{"system":"sec-edgar","filing":"0000950170-24-046598","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000095017024046598/ownership.xml","form_type":"4"}},{"id":1672799,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2024-01-24T00:17:23.000Z","date":"2024-01-20","kind":"exercise","planned":true,"acquired":false,"shares":266720,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":533280,"derivative":{"underlying":"Common Stock","underlying_shares":266720},"source":{"system":"sec-edgar","filing":"0001209191-24-002119","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919124002119/doc4.xml","form_type":"4"}},{"id":1672798,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-01-24T00:17:23.000Z","date":"2024-01-22","kind":"sale","planned":true,"acquired":false,"shares":137390,"price":0.36,"value":49460.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales were effected pursuant to a Rule 10b5-1 plan adopted on March 24, 2022. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees."}],"balance_after":356433,"source":{"system":"sec-edgar","filing":"0001209191-24-002119","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919124002119/doc4.xml","form_type":"4"}},{"id":1672797,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-01-24T00:17:23.000Z","date":"2024-01-20","kind":"exercise","planned":true,"acquired":true,"shares":266720,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the partial vesting and settlement of Restricted Stock Units (\"RSUs\") on January 20, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share."}],"balance_after":493823,"source":{"system":"sec-edgar","filing":"0001209191-24-002119","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919124002119/doc4.xml","form_type":"4"}},{"id":1748460,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2023-11-06T22:07:41.000Z","date":"2023-11-02","kind":"exercise","planned":true,"acquired":false,"shares":283390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":566610,"derivative":{"underlying":"Common Stock","underlying_shares":283390},"source":{"system":"sec-edgar","filing":"0001209191-23-054549","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919123054549/doc4.xml","form_type":"4"}},{"id":1748459,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-11-06T22:07:41.000Z","date":"2023-11-03","kind":"sale","planned":true,"acquired":false,"shares":125025,"price":0.4,"value":50010.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales were effected pursuant to a Rule 10b5-1 plan adopted on March 24, 2022. The transaction was a sell-to-cover, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs."}],"balance_after":227103,"source":{"system":"sec-edgar","filing":"0001209191-23-054549","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919123054549/doc4.xml","form_type":"4"}},{"id":1748458,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-11-06T22:07:41.000Z","date":"2023-11-02","kind":"exercise","planned":true,"acquired":true,"shares":283390,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the partial vesting and settlement of Restricted Stock Units (\"RSUs\") on November 2, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share."}],"balance_after":352128,"source":{"system":"sec-edgar","filing":"0001209191-23-054549","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919123054549/doc4.xml","form_type":"4"}},{"id":1771878,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-29T20:30:11.000Z","date":"2023-09-27","kind":"sale","planned":false,"acquired":false,"shares":5508,"price":3.9111,"value":21542.3388,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Weighted average price. These shares were sold in multiple transactions at prices ranging from $3.8200 to $4.2000 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":108957,"source":{"system":"sec-edgar","filing":"0001493152-23-034855","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315223034855/ownership.xml","form_type":"4"}},{"id":1775109,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-22T20:05:28.000Z","date":"2023-09-20","kind":"sale","planned":false,"acquired":false,"shares":327,"price":3.9,"value":1275.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was to cover tax obligations associated with vesting of restricted stock awards."}],"balance_after":114465,"source":{"system":"sec-edgar","filing":"0001493152-23-033446","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315223033446/ownership.xml","form_type":"4"}},{"id":1848354,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-21T20:05:11.000Z","date":"2023-06-20","kind":"sale","planned":false,"acquired":false,"shares":338,"price":4.45,"value":1504.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with vesting of restricted stock awards."}],"balance_after":114792,"source":{"system":"sec-edgar","filing":"0001493152-23-021996","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315223021996/ownership.xml","form_type":"4"}},{"id":1853511,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T20:05:30.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":58689,"price":4.62,"value":271143.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All of the restricted stock will vest on June 14, 2024."}],"balance_after":115130,"source":{"system":"sec-edgar","filing":"0001493152-23-021653","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315223021653/ownership.xml","form_type":"4"}},{"id":1940023,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2023-03-23T20:00:11.000Z","date":"2023-03-21","kind":"exercise","planned":true,"acquired":false,"shares":102535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 21, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 21, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 21, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 21, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":205009,"derivative":{"underlying":"Common Stock","underlying_shares":102535},"source":{"system":"sec-edgar","filing":"0001209191-23-020716","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919123020716/doc4.xml","form_type":"4"}},{"id":1940022,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-03-23T20:00:11.000Z","date":"2023-03-22","kind":"sale","planned":true,"acquired":false,"shares":46999,"price":0.82,"value":38539.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs."}],"balance_after":68738,"source":{"system":"sec-edgar","filing":"0001209191-23-020716","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919123020716/doc4.xml","form_type":"4"}},{"id":1940021,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-03-23T20:00:11.000Z","date":"2023-03-21","kind":"exercise","planned":true,"acquired":true,"shares":102535,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the partial vesting and settlement of Restricted Stock Units (\"RSUs\") on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":115737,"source":{"system":"sec-edgar","filing":"0001209191-23-020716","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919123020716/doc4.xml","form_type":"4"}},{"id":1943842,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-21T21:13:23.000Z","date":"2023-03-20","kind":"sale","planned":false,"acquired":false,"shares":268,"price":2.33,"value":624.44,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with vesting of restricted stock awards."}],"balance_after":56441,"source":{"system":"sec-edgar","filing":"0001493152-23-008429","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315223008429/ownership.xml","form_type":"4"}},{"id":1977146,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-04T00:06:07.000Z","date":"2023-03-03","kind":"sale","acquired":false,"shares":1002,"price":2.38,"value":2384.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with vesting of restricted stock awards."}],"balance_after":56709,"source":{"system":"sec-edgar","filing":"0001493152-23-006716","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315223006716/ownership.xml","form_type":"4"}},{"id":2047307,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2023-01-24T21:30:21.000Z","date":"2023-01-20","kind":"grant","acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award vests in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Award vests in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":800000,"derivative":{"underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001209191-23-004608","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919123004608/doc4.xml","form_type":"4"}},{"id":2124507,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2022-11-04T20:11:27.000Z","date":"2022-11-02","kind":"grant","acquired":true,"shares":850000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award represents a retention grant, which vests in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Award represents a retention grant, which vests in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":850000,"derivative":{"underlying":"Common Stock","underlying_shares":850000},"source":{"system":"sec-edgar","filing":"0001209191-22-055786","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919122055786/doc4.xml","form_type":"4"}},{"id":2131530,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-26T11:00:09.000Z","date":"2022-10-24","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Reporting Person was granted stock options in accordance with the Reporting Person's employment agreement with the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 25% of the underlying shares on October 15, 2023 and thereafter in twelve substantially equal installments at the end of each three-month period over the 36 months following such date, subject to the Reporting Person's continued service to the Company through the applicable vesting dates."}],"balance_after":250000,"derivative":{"exercise_price":1.38,"expiration_date":"2032-10-23","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001209191-22-054587","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919122054587/doc4.xml","form_type":"4"}},{"id":2135362,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2022-10-18T20:13:05.000Z","date":"2022-10-15","kind":"exercise","acquired":false,"shares":24208,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On October 15, 2021 the Reporting Person was granted RSUs, which vested on October 15, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On October 15, 2021 the Reporting Person was granted RSUs, which vested on October 15, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":24208},"source":{"system":"sec-edgar","filing":"0001209191-22-053956","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919122053956/doc4.xml","form_type":"4"}},{"id":2135361,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-10-18T20:13:05.000Z","date":"2022-10-17","kind":"sale","acquired":false,"shares":11006,"price":1.32,"value":14527.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs."}],"balance_after":13202,"source":{"system":"sec-edgar","filing":"0001209191-22-053956","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919122053956/doc4.xml","form_type":"4"}},{"id":2135360,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-10-18T20:13:05.000Z","date":"2022-10-15","kind":"exercise","acquired":true,"shares":24208,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the vesting and settlement of Restricted Stock Units (\"RSUs\") on October 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":24208,"source":{"system":"sec-edgar","filing":"0001209191-22-053956","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919122053956/doc4.xml","form_type":"4"}},{"id":2150197,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-28T20:36:44.000Z","date":"2022-09-26","kind":"grant","acquired":true,"shares":13400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All of the restricted stock will vest on September 26, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On July 1, 2022, the issuer effectuated a 1-for-25 reverse stock split."}],"balance_after":57711,"source":{"system":"sec-edgar","filing":"0001493152-22-027048","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315222027048/ownership.xml","form_type":"4"}},{"id":2319882,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2022-03-23T21:00:19.000Z","date":"2022-03-21","kind":"grant","acquired":true,"shares":307544,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which each represent a contingent right to receive one share of the Company's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest in three substantially equal annual installments beginning on March 21, 2023, subject to the Reporting Person's continued service to the Company through the applicable vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest in three substantially equal annual installments beginning on March 21, 2023, subject to the Reporting Person's continued service to the Company through the applicable vesting dates."}],"balance_after":307544,"derivative":{"underlying":"Common Stock","underlying_shares":307544},"source":{"system":"sec-edgar","filing":"0001209191-22-020793","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919122020793/doc4.xml","form_type":"4"}},{"id":2319881,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-03-23T21:00:19.000Z","date":"2022-03-21","kind":"grant","acquired":true,"shares":482771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the underlying shares on March 21, 2023 and thereafter in twelve substantially equal installments at the end of each three-month period over the 36 months following such date, subject to the Reporting Person's continued service to the Company through the applicable vesting dates."}],"balance_after":482771,"derivative":{"exercise_price":3.05,"expiration_date":"2032-03-20","underlying":"Common Stock","underlying_shares":482771},"source":{"system":"sec-edgar","filing":"0001209191-22-020793","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919122020793/doc4.xml","form_type":"4"}},{"id":2538920,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2021-10-19T20:09:38.000Z","date":"2021-10-15","kind":"grant","acquired":true,"shares":24208,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which each represent a contingent right to receive one share of the Company's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest on October 15, 2022, subject to the Reporting Person's continued service to the Company through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest on October 15, 2022, subject to the Reporting Person's continued service to the Company through the vesting date."}],"balance_after":24208,"derivative":{"underlying":"Common Stock","underlying_shares":24208},"source":{"system":"sec-edgar","filing":"0001209191-21-060890","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121060890/doc4.xml","form_type":"4"}},{"id":2538919,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-10-19T20:09:38.000Z","date":"2021-10-15","kind":"grant","acquired":true,"shares":850000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the underlying shares on October 15, 2022 and thereafter in twelve equal installments at the end of each three-month period over the 36 months following such date, subject to the Reporting Person's continued service to the Company through the applicable vesting dates."}],"balance_after":850000,"derivative":{"exercise_price":9.79,"expiration_date":"2031-10-14","underlying":"Common Stock","underlying_shares":850000},"source":{"system":"sec-edgar","filing":"0001209191-21-060890","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121060890/doc4.xml","form_type":"4"}},{"id":2553364,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common stock","published_at":"2021-10-04T20:06:05.000Z","date":"2021-09-30","kind":"sale","acquired":false,"shares":45409,"price":1.0875,"value":49382.2875,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to cover tax obligations associated with vested restricted stock awards and were effected pursuant to a Rule 10b5-1 trading plan adopted by Michael Amoroso on February 24, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.08 to $1.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote."}],"balance_after":604637,"source":{"system":"sec-edgar","filing":"0001493152-21-024499","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221024499/ownership.xml","form_type":"4"}},{"id":2762813,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common stock","published_at":"2021-04-02T23:12:54.000Z","date":"2021-03-31","kind":"sale","acquired":false,"shares":45409,"price":1.8701,"value":84919.3709,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Michael Amoroso on February 24, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.805 to $1.945, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote."}],"balance_after":650046,"source":{"system":"sec-edgar","filing":"0001493152-21-007902","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221007902/ownership.xml","form_type":"4"}},{"id":2775655,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-23T20:08:26.000Z","date":"2021-03-19","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest 25% on March 19, 2022, and in 36 equal monthly installments thereafter."}],"balance_after":500000,"derivative":{"exercise_price":2.18,"expiration_date":"2031-03-19","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001493152-21-006622","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221006622/ownership.xml","form_type":"4"}},{"id":2775654,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common stock","published_at":"2021-03-23T20:08:26.000Z","date":"2021-03-19","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock will vest 25% on each of March 19, 2022 and in 12 quarterly installments thereafter."}],"balance_after":695455,"source":{"system":"sec-edgar","filing":"0001493152-21-006622","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221006622/ownership.xml","form_type":"4"}},{"id":2817038,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-03T21:05:44.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest 25% on March 1, 2022, and in 36 equal monthly installments thereafter."}],"balance_after":400000,"derivative":{"exercise_price":2.34,"expiration_date":"2031-03-01","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001493152-21-005275","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221005275/ownership.xml","form_type":"4"}},{"id":2817037,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common stock","published_at":"2021-03-03T21:05:44.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock will vest 25% on each of March 1, 2022, March 1, 2023, March 1, 2024 and March 1, 2025."}],"balance_after":445455,"source":{"system":"sec-edgar","filing":"0001493152-21-005275","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221005275/ownership.xml","form_type":"4"}},{"id":2972196,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:10.000Z","date":"2020-11-20","kind":"disposition_to_issuer","acquired":false,"shares":250000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on July 9, 2020 have been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 25% on July 9, 2021, and in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":3.35,"expiration_date":"2030-11-02","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001493152-20-022152","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022152/ownership.xml","form_type":"4"}},{"id":2972195,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:10.000Z","date":"2020-11-20","kind":"grant","acquired":true,"shares":250000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on July 9, 2020 have been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 25% on July 9, 2021, and in 36 equal monthly installments thereafter."}],"balance_after":250000,"derivative":{"exercise_price":1.15,"expiration_date":"2030-11-02","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001493152-20-022152","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022152/ownership.xml","form_type":"4"}},{"id":2993656,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":41656,"kind":"person","name":"Amoroso Michael","position":1,"cik":"0001830874","reported_name":"Amoroso Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-04T21:12:48.000Z","date":"2020-11-02","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest 25% on November 2, 2021, and in 36 equal monthly installments thereafter."}],"balance_after":100000,"derivative":{"exercise_price":1.07,"expiration_date":"2030-11-02","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001641172-20-000031","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000164117220000031/ownership.xml","form_type":"4"}}]}